Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EXOC4 - U373MG glioblastoma cell line response to 3 anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EXOC4 - Parkin expression in parkin-deficient U87MG glioma cells
EXOC4 - True interval breast cancer
EXOC4 - Triple negative breast cancer
EXOC4 - Protein tyrosine kinase PTK7 knockdown effect on lung adenocarcinoma cell lines
EXOC4 - Sunitinib effect on renal cancer xenograft tumors
EXOC4 - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
EXOC4 - Cancer stem cell population in highly metastatic variants of MDA-MB-231 breast cancer cell line
EXOC4 - Co-expression of tyrosine kinase receptors HER2 and HER3 in mammary epithelial cells MCF10A grown in three-dimensional cultures
EXOC4 - Sustained olive oil consumption effect on peripheral blood mononuclear cells
EXOC4 - Keratinocyte response to endogenous microRNA-31 inhibition
EXOC4 - Oncogenic BRAF harboring melanoma cell line response to BRAF inhibition
EXOC4 - Rapamycin-resistant diffuse large B-cell lymphoma cell lines
EXOC4 - Insulin-Producing Cells generated from dedifferentiated pancreatic islet cells expanded in vitro
EXOC4 - Stem cell factor SOX2-deficient stomach carcinoma cell line: time course
EXOC4 - Glucosamine treatment effect on KMH2 malignant lymphocytes
EXOC4 - Oligooxopiperazine effect on hypoxic alveolar adenocarcinoma cell line
EXOC4 - CD138- and CD138+ FACS-sorted myeloma cell lines
EXOC4 - BET bromodomain inhibitor JQ1 effect on MYC-amplified medulloblastoma cell lines
EXOC4 - Saracatinib-sensitive versus -resistant, PIK3CA mutant colorectal cancer xenografts
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on